Italy· 040673055

MONTELUKAST TEVA

A montelukast product containing montelukast, registered in Italy by TEVA ITALIA S.R.L., on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC R03DC03

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedMONTELUKAST TEVAATCR03DC03REGISTER NO.040673055PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Montelukast is registered in 19 of 19 countries.

Countries holding a registration under ATC R03DC03 (montelukast), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 11 of them publish a price we can compare per daily dose

Montelukast · ATC R03DC03

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of montelukast costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in Italy to $1.71 in Spain — a ×2.9 gap.

  • Italy: $0.59 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Montelukast · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • ES Spain$1.71
  • CH Switzerland$1.41
  • FR France$0.71
  • IT Italy$0.59
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Montelukast
Manufacturer
TEVA ITALIA S.R.L.
Country
Italy (IT)
ATC code
R03DC03
ATC class
Montelukast
Defined daily dose
10 mg, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    040673055
    "10 MG COMPRESSE RIVESTITE CON FILM" 28 COMPRESSE IN BLISTER AL/AL
    EUR 14.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

565 interactions on record for montelukast.

Graded by severity as the source publishes them — 101 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Montelukast · interactions on record

565 records

  • 101 moderate
  • 464 info

Most severe, free to view

  • MiconazoleA07AC01moderate
  • TroglitazoneA10BG01moderate
  • NateglinideA10BX03moderate
  • NitisinoneA16AX04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Montelukast in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All montelukast products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Lanair, Montelukast +pharma
  • Belgium · Montelukast Ab, Montelukast Eg
  • Bulgaria · Eфира, Moнтелукаст Акорд
  • Cyprus · Modulair, Montelukast Krka
  • Czechia · Castispir, Monkasta
  • Germany · Monkasta, Montelair Hexal
  • Denmark · Montelukast "sandoz", Montelukast Accord Healthcare
  • Estonia · Monkasta, Montelukast Teva
  • Spain · Monkasta, Montelukast Accord
  • Finland · Montelukast, Montelukast Accord
  • France · Montelukast Accord, Montelukast Accord Healthcare
  • United Kingdom (Northern Ireland) · Montelukast, Montelukast for Children From 6 To 14 Years Accord Healthcare
  • Greece · Apilone, Ascolin
  • Croatia · Melarth, Monkasta
  • Hungary · Eonic, Monalux
  • Ireland · Montelair, Montelukast
  • Iceland · Montelukast Alvogen, Singulair
  • Lithuania · Monkasta
  • Luxembourg · Montelukast Eurogenerics, Montelukast Ratiopharm
  • Latvia · Monkasta
  • Malta · Actamone, Monkasta
  • Netherlands · Montelukast Accord, Montelukast Amarox
  • Norway · Montelukast Krka, Montelukast Sandoz
  • Poland · Asmenol, Astmodil
  • Portugal · Montelucaste Accord, Montelucaste Alter
  • Romania · Monkasta, Montelukast Arena
  • Sweden · Montelukast Accord, Montelukast Amarox
  • Slovenia · Monkasta, Singulair
  • Slovakia · Astmasan, Belokast

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b35151fc-fd27-4b08-8a13-ca7419712ced
GET /v1/drugs/b35151fc-fd27-4b08-8a13-ca7419712ced?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"10 MG COMPRESSE RIVESTITE CON FILM\" 28 COMPRESSE IN BLISTER AL/AL",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Montelukast",
  "reference_pack": "28 UNITA' 10 MG - USO ORALE",
  "public_price_eur": 14.5,
  "ssn_reference_price_eur": 14.5
}

See everything about montelukast.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.